CHLORDIAZEPOXIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlordiazepoxide and what is the scope of patent protection?
Chlordiazepoxide
is the generic ingredient in twelve branded drugs marketed by Valeant Pharm Intl, Abbott, Rachelle, Ascot, Barr, Chartwell Rx, Ferrante, Halsey, Impax Labs, Ivax Sub Teva Pharms, Lederle, Mast Mm, Mylan, Parke Davis, Pioneer Pharms, Purepac Pharm, Roxane, Superpharm, Teva, Upsher Smith Labs, Usl Pharma, Vangard, Watson Labs, West Ward, Bausch, Alra, Alembic, Alkem Labs Ltd, Amneal, Aurobindo Pharma Ltd, Corepharma, Dr Reddys, Micro Labs, Misemer, Nuvo Pharms Inc, Teva Pharms Usa, Torrent, Winder Labs Llc, and Roche, and is included in ninety-eight NDAs. Additional information is available in the individual branded drug profile pages.There are nine drug master file entries for chlordiazepoxide.
Summary for CHLORDIAZEPOXIDE
US Patents: | 0 |
Tradenames: | 12 |
Applicants: | 39 |
NDAs: | 98 |
Drug Master File Entries: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Clinical Trials: | 8 |
Patent Applications: | 6,859 |
Drug Prices: | Drug price trends for CHLORDIAZEPOXIDE |
What excipients (inactive ingredients) are in CHLORDIAZEPOXIDE? | CHLORDIAZEPOXIDE excipients list |
DailyMed Link: | CHLORDIAZEPOXIDE at DailyMed |
Recent Clinical Trials for CHLORDIAZEPOXIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 4 |
Oregon Health and Science University | Phase 2 |
Chang Gung Memorial Hospital | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for CHLORDIAZEPOXIDE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORDIAZEPOXIDE
US Patents and Regulatory Information for CHLORDIAZEPOXIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alra | LYGEN | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085107-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Alembic | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | chlordiazepoxide hydrochloride; clidinium bromide | CAPSULE;ORAL | 216969-001 | Sep 15, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
West Ward | CHLORDIAZEPOXIDE HYDROCHLORIDE | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085294-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CHLORDIAZEPOXIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Pharm Intl | LIBRELEASE | chlordiazepoxide | CAPSULE, EXTENDED RELEASE;ORAL | 017813-001 | Sep 12, 1983 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |